Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/18/08 → 12/18/11 |
Funding
- Gilead Sciences, Inc (GS-US-196-0103)
Prot# GS-US-196-0103: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Comparing 24 or 48 Weeks of GS-9190, in Combination with Peginterferon Alpha 2a and Ribavirin, to 48 Weeks of Peginterferon Alpha 2a and Ribavirin for the Treatment of Ge
- Flamm, Steven L (PD/PI)
- Ganger, Daniel R (Co-PD/PI)
Project: Research project